At TissueMetrics we have developed a world’s first non-invasive, handheld acoustic sensing technology that uses sound waves to evaluate the elasticity (stiffness) and viscoelasticity (fluid content) of each skin layer in just a few seconds and with no skin tone bias. We provide users with “x-ray eyes” where sub-surface changes in tissue health can be detected before surface-level presentation. With our device, users can scan an ISD-affected region (using a non-ISD region as a control), administer treatment, and reassess after just one week instead of the current six-week wait. By leveraging our quantitative metrics, they can quickly make data-driven decisions and adjust the patient’s care plan as needed. We are turning this into a service that can be provided by pharmacies which will enable community healthcare provision rather than relying on skilled clinician access.